Hala M. Fadda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hala M. Fadda has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Monika Fischer
Indiana University Division of Gastroenterology and Hepatology, Indianapolis, IN, USA
3 shared publicationsAktham Aburub
Synthetic Molecule Design and Development, Lilly Research Labs, Eli Lilly & Company, Indianapolis, USA
2 shared publicationsPeng T. Khaw
National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, EC1 V9EL, UK
2 shared publicationsShivi Siva
Indiana University Division of Gastroenterology and Hepatology, Indianapolis, IN, USA
2 shared publicationsA. Aburub
Small Molecule Design and Development, Lilly Research Labs, Eli Lilly & Company, Indianapolis, IN, United States
1 shared publicationA. Mitra
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University , Indianapolis, Indiana 46208, United States
1 shared publication
Latest Publications
- Open Access
- 16 March 2026
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (6) , 1785-1797
Age-Appropriateness of Oral Formulations Authorized for Pediatrics
Purpose: Pediatric global regulatory initiatives have come into place to address gaps in evidence-based medicine for children. Objective of this study was to assess age-appropriateness of oral pediatric formulations authorized through the U.S. Food and Drug Administration’s Pediatric Rule, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act. Methods: Formulation age-appropriateness was assessed using an adapted version of the World Health Organization pediatric quality product profile assessment tool. Evaluations encompassed four product attributes across pediatric subgroups: dose and dose flexibility, patient acceptability, excipient safety and administration considerations. Each attribute was scored on a three-point scale: 1 indicating high risk, 2 moderate risk, and 3 low risk. Results: 214 oral formulations were evaluated. Age-appropriateness remains a concern; with less than one third of authorized oral formulations for neonates meeting criteria for age-appropriateness, in comparison to 66% for older pediatric populations. Tablets and capsules constitute 58% of formulations indicated for pediatrics, despite tablet sizes often being unsuitable for younger children. Liquid formulations for neonates present a significant oversight, as they frequently contain excipients of potential concern. As children age, swallowability of the dosage form appears to be deprioritized, with only 37% of unswallowable large size tablets for school-aged children, available in alternative dosage forms such as granules, or solids for dispersions. Conclusions: Significant formulation gaps persist in pediatric medicine, with acceptability and excipient safety presenting highest risk. The potential of non-conventional solid dosage forms remains underutilized, underscoring the need for regulatory frameworks to support development of pediatric medicines.
- 16 March 2026
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (6) , 1785-1797
Open AccessAge-Appropriateness of Oral Formulations Authorized for Pediatrics
Purpose: Pediatric global regulatory initiatives have come into place to address gaps in evidence-based medicine for children. Objective of this study was to assess age-appropriateness of oral pediatric formulations authorized through the U.S. Food and Drug Administration’s Pediatric Rule, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act. Methods: Formulation age-appropriateness was assessed using an adapted version of the World Health Organization pediatric quality product profile assessment tool. Evaluations encompassed four product attributes across pediatric subgroups: dose and dose flexibility, patient acceptability, excipient safety and administration considerations. Each attribute was scored on a three-point scale: 1 indicating high risk, 2 moderate risk, and 3 low risk. Results: 214 oral formulations were evaluated. Age-appropriateness remains a concern; with less than one third of authorized oral formulations for neonates meeting criteria for age-appropriateness, in comparison to 66% for older pediatric populations. Tablets and capsules constitute 58% of formulations indicated for pediatrics, despite tablet sizes often being unsuitable for younger children. Liquid formulations for neonates present a significant oversight, as they frequently contain excipients of potential concern. As children age, swallowability of the dosage form appears to be deprioritized, with only 37% of unswallowable large size tablets for school-aged children, available in alternative dosage forms such as granules, or solids for dispersions. Conclusions: Significant formulation gaps persist in pediatric medicine, with acceptability and excipient safety presenting highest risk. The potential of non-conventional solid dosage forms remains underutilized, underscoring the need for regulatory frameworks to support development of pediatric medicines.
- 20 February 2026
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (3) , 101951
Are Pharmacy Programs Obligated to Train Students to Use AI for Clinical Practice?
- 20 February 2026
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (3) , 101951
Are Pharmacy Programs Obligated to Train Students to Use AI for Clinical Practice?
- 6 September 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 204, 114483
Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study
- 6 September 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 204, 114483
Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study
- Open Access
- 18 November 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (11) , 2505
Drug Physicochemical Properties and Capsule Fill Determine Extent of Premature Gastric Release from Enteric Capsules
Intrinsically, enteric capsule shells offer several advantages compared to coating of dosage forms with enteric polymers. We undertook a systematic investigation to elucidate capsule-fill parameters that may result in premature gastric drug release from Vcaps® Enteric capsules (Lonza CHI, Morristown, NJ, USA). Four model drugs with different ionization and solubility profiles were investigated: acetaminophen, ketoprofen, trimethoprim and atenolol. Different fill loads, diluents and drug-to-diluent ratios were explored. Enteric capsules were filled with drug or drug and diluent powder mix and underwent USP II dissolution testing using mini-vessels and paddles. Capsules were tested in pH 2 (0.01 M HCl) or pH 4.5 (3.2 × 10−5 M HCl) 200 mL acid media to simulate normal, fasted or hypochlorhydric gastric pH, respectively. Acetaminophen, trimethoprim and atenolol displayed premature gastric drug release from enteric capsules. The extent of premature release was dependent on drug solubility, ionization profile and capsule-fill level. At 100 mg drug-fill level, acetaminophen, trimethoprim and atenolol gave rise to 10.6, 12.2 and 83.1% drug release, respectively, in normal, fasted, gastric fluids. Diffusion layer pH of trimethoprim and atenolol in pH 2 media was determined to be pH 6.3 and 10.3, respectively. Upon increasing capsule-fill load using microcrystalline cellulose as a diluent, a significant reduction in premature gastric release was observed. However, including mannitol as a diluent was only effective at decreasing premature drug release at a low drug-to-diluent ratio. Systematic in vitro screening of enteric capsule fills needs to be conducted to ensure that drug product performance is not compromised.
- 18 November 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (11) , 2505
Open AccessDrug Physicochemical Properties and Capsule Fill Determine Extent of Premature Gastric Release from Enteric Capsules
Intrinsically, enteric capsule shells offer several advantages compared to coating of dosage forms with enteric polymers. We undertook a systematic investigation to elucidate capsule-fill parameters that may result in premature gastric drug release from Vcaps® Enteric capsules (Lonza CHI, Morristown, NJ, USA). Four model drugs with different ionization and solubility profiles were investigated: acetaminophen, ketoprofen, trimethoprim and atenolol. Different fill loads, diluents and drug-to-diluent ratios were explored. Enteric capsules were filled with drug or drug and diluent powder mix and underwent USP II dissolution testing using mini-vessels and paddles. Capsules were tested in pH 2 (0.01 M HCl) or pH 4.5 (3.2 × 10−5 M HCl) 200 mL acid media to simulate normal, fasted or hypochlorhydric gastric pH, respectively. Acetaminophen, trimethoprim and atenolol displayed premature gastric drug release from enteric capsules. The extent of premature release was dependent on drug solubility, ionization profile and capsule-fill level. At 100 mg drug-fill level, acetaminophen, trimethoprim and atenolol gave rise to 10.6, 12.2 and 83.1% drug release, respectively, in normal, fasted, gastric fluids. Diffusion layer pH of trimethoprim and atenolol in pH 2 media was determined to be pH 6.3 and 10.3, respectively. Upon increasing capsule-fill load using microcrystalline cellulose as a diluent, a significant reduction in premature gastric release was observed. However, including mannitol as a diluent was only effective at decreasing premature drug release at a low drug-to-diluent ratio. Systematic in vitro screening of enteric capsule fills needs to be conducted to ensure that drug product performance is not compromised.
- 30 July 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 625, 122069
Intra- and inter-subject variability in gastric pH following a low-fat, low-calorie meal
- 30 July 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 625, 122069
Intra- and inter-subject variability in gastric pH following a low-fat, low-calorie meal
- 1 July 2022
- Published by Springer Nature in Pharmaceutical Research
- Vol. 39 (9) , 2217-2226
Vitamin C Improves Dasatinib Concentrations Under Hypochlorhydric Conditions of the Simulated Stomach Duodenum Model
Purpose pH-dependent drug-drug interactions (DDIs) with poorly soluble, weakly basic drugs may lead to clinical implications. Dasatinib is a tyrosine kinase inhibitor with reduced absorption in patients on acid-reducing agents (ARAs). The objective of this study is to investigate the influence of gastric pH on dasatinib supersaturation and determine if vitamin C (L-ascorbic acid) can improve dasatinib concentrations under simulated hypochlorhydric gastric conditions. Methods A dynamic, in vitro, multi-compartment, simulated stomach duodenum (SSD) model mimicking fluid volumes and transfer rates was used to investigate the concentration of BCS class IIb drugs versus time curves. Dasatinib and lamotrigine were explored under normal, fasted, simulated gastric fluids (pH 2) (FaSGF), hypochlorhydric simulated gastric fluids (pH 4.5) (FaSGFhypo) and FaSGFhypo with 1000 mg of vitamin C. Results Significant supersaturation of dasatinib was observed in the duodenum compartment of the SSD model in FaSGF. A 90% reduction in dasatinib AUC∞ was observed in FaSGFhypo. Upon addition of vitamin C to FaSGFhypo, drug concentrations were restored to those observed in FaSGF. Lamotrigine AUC∞ in the duodenal compartment were similar in both FaSGF and FaSGFhypo. The in vitro trends observed for dasatinib and lamotrigine are reflective of the trends observed in vivo in subjects receiving treatment with ARAs. Conclusions The SSD model serves as a good in vitro tool for assessing the effect of pH-dependent DDIs on bioavailability of weakly basic drugs with solubility/ dissolution limited absorption. Vitamin C provides a promising approach for improving bioavailability of poorly soluble, weakly basic drugs in hypochlorhydric patients.
- 1 July 2022
- Published by Springer Nature in Pharmaceutical Research
- Vol. 39 (9) , 2217-2226
Vitamin C Improves Dasatinib Concentrations Under Hypochlorhydric Conditions of the Simulated Stomach Duodenum Model
Purpose pH-dependent drug-drug interactions (DDIs) with poorly soluble, weakly basic drugs may lead to clinical implications. Dasatinib is a tyrosine kinase inhibitor with reduced absorption in patients on acid-reducing agents (ARAs). The objective of this study is to investigate the influence of gastric pH on dasatinib supersaturation and determine if vitamin C (L-ascorbic acid) can improve dasatinib concentrations under simulated hypochlorhydric gastric conditions. Methods A dynamic, in vitro, multi-compartment, simulated stomach duodenum (SSD) model mimicking fluid volumes and transfer rates was used to investigate the concentration of BCS class IIb drugs versus time curves. Dasatinib and lamotrigine were explored under normal, fasted, simulated gastric fluids (pH 2) (FaSGF), hypochlorhydric simulated gastric fluids (pH 4.5) (FaSGFhypo) and FaSGFhypo with 1000 mg of vitamin C. Results Significant supersaturation of dasatinib was observed in the duodenum compartment of the SSD model in FaSGF. A 90% reduction in dasatinib AUC∞ was observed in FaSGFhypo. Upon addition of vitamin C to FaSGFhypo, drug concentrations were restored to those observed in FaSGF. Lamotrigine AUC∞ in the duodenal compartment were similar in both FaSGF and FaSGFhypo. The in vitro trends observed for dasatinib and lamotrigine are reflective of the trends observed in vivo in subjects receiving treatment with ARAs. Conclusions The SSD model serves as a good in vitro tool for assessing the effect of pH-dependent DDIs on bioavailability of weakly basic drugs with solubility/ dissolution limited absorption. Vitamin C provides a promising approach for improving bioavailability of poorly soluble, weakly basic drugs in hypochlorhydric patients.
- 15 April 2020
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 21 (3) , 1-21
The Route to Palatable Fecal Microbiota Transplantation
The community of symbiotic microorganisms that reside in our gastrointestinal tract is integral to human health. Fecal microbiota transplantation (FMT) has
- 15 April 2020
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 21 (3) , 1-21
The Route to Palatable Fecal Microbiota Transplantation
The community of symbiotic microorganisms that reside in our gastrointestinal tract is integral to human health. Fecal microbiota transplantation (FMT) has
- 1 January 2020
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 20 (2) , 43-44
Group activities and game-based learning to keep students connected to their academic communities
Challenges experienced by students with online teaching include maintaining connectivity to the academic community. To overcome students feeling 'silo-ed' and to maintain their motivation, the faculty at Butler University enhanced group activities with game-based learning. Group activities included problem-based learning exercises and students working together to expand concept maps. These provided the opportunity for students to interact with the content, to interact with their peers and to interact with faculty. Students found these group activities effective ways of applying their knowledge in a timely manner. Game-based learning platforms that were utilised included quizzes that took place in-class as well as during review sessions. These enabled students to keep abreast of the material they were learning in class and identify gaps in their comprehension. The quizzes generated dynamic class discussions which enabled students to learn from each other.
- 1 January 2020
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 20 (2) , 43-44
Group activities and game-based learning to keep students connected to their academic communities
Challenges experienced by students with online teaching include maintaining connectivity to the academic community. To overcome students feeling 'silo-ed' and to maintain their motivation, the faculty at Butler University enhanced group activities with game-based learning. Group activities included problem-based learning exercises and students working together to expand concept maps. These provided the opportunity for students to interact with the content, to interact with their peers and to interact with faculty. Students found these group activities effective ways of applying their knowledge in a timely manner. Game-based learning platforms that were utilised included quizzes that took place in-class as well as during review sessions. These enabled students to keep abreast of the material they were learning in class and identify gaps in their comprehension. The quizzes generated dynamic class discussions which enabled students to learn from each other.
- 1 January 2019
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (1) , 288-294
A Simulated Stomach Duodenum Model Predicting the Effect of Fluid Volume and Prandial Gastric Flow Patterns on Nifedipine Pharmacokinetics From Cosolvent-Based Capsules
- 1 January 2019
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (1) , 288-294
A Simulated Stomach Duodenum Model Predicting the Effect of Fluid Volume and Prandial Gastric Flow Patterns on Nifedipine Pharmacokinetics From Cosolvent-Based Capsules